Intravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy rats
- PMID: 18374523
- DOI: 10.1016/j.toxlet.2008.01.020
Intravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy rats
Abstract
A comparative toxicological study of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles coated with polysorbate 80 was performed in male and female Wistar rats. The drug substance was used as a reference formulation. The formulations were injected intravenously at a therapeutic dose of 6 mg/kg administered either as a single injection or in form of four weekly injections. The animals were followed up for 4 and 40 days (single injection) or 25 and 61 days (multiple injections) for assessment of the dynamics of body weight, hematological parameters, blood biochemical parameters, and urinalysis. Pathomorphological evaluation included macroscopic evaluation and weight measurement of the internal organs. The heart, lung, spleen, testes, and liver were also subjected to the histological evaluation. The overall result of this study suggests that the surfactant-coated nanoparticle formulation of doxorubicin has a favorable toxicological profile. Specifically, this formulation displays a considerably reduced cardio- and testicular toxicity, as compared to a free drug.
Similar articles
-
Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: focus on cardio- and testicular toxicity.Int J Pharm. 2007 Jun 7;337(1-2):346-56. doi: 10.1016/j.ijpharm.2007.01.031. Epub 2007 Jan 28. Int J Pharm. 2007. PMID: 17306479
-
Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma.Toxicol Lett. 2002 Jan 25;126(2):131-41. doi: 10.1016/s0378-4274(01)00456-8. Toxicol Lett. 2002. PMID: 11751017
-
Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles.Eur J Pharm Biopharm. 2008 Sep;70(1):75-84. doi: 10.1016/j.ejpb.2008.03.009. Epub 2008 Mar 27. Eur J Pharm Biopharm. 2008. PMID: 18472255
-
Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.Pharm Res. 1999 Oct;16(10):1564-9. doi: 10.1023/a:1018983904537. Pharm Res. 1999. PMID: 10554098
-
Nanoparticle formulations in pulmonary drug delivery.Med Res Rev. 2009 Jan;29(1):196-212. doi: 10.1002/med.20140. Med Res Rev. 2009. PMID: 18958847 Review.
Cited by
-
Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterization.Theranostics. 2012;2(11):1092-103. doi: 10.7150/thno.4949. Epub 2012 Nov 13. Theranostics. 2012. PMID: 23227125 Free PMC article.
-
Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(butylcyanoacrylate) nanoparticles.Drug Des Devel Ther. 2015 Dec 14;9:6433-44. doi: 10.2147/DDDT.S92273. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26715840 Free PMC article.
-
Green Tea Catechin-Based Complex Micelles Combined with Doxorubicin to Overcome Cardiotoxicity and Multidrug Resistance.Theranostics. 2016 Jun 6;6(9):1277-92. doi: 10.7150/thno.15133. eCollection 2016. Theranostics. 2016. PMID: 27375779 Free PMC article.
-
In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles.Proc Natl Acad Sci U S A. 2011 Nov 29;108(48):19347-52. doi: 10.1073/pnas.1115945108. Epub 2011 Nov 15. Proc Natl Acad Sci U S A. 2011. PMID: 22087004 Free PMC article.
-
Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.J Neuroimmune Pharmacol. 2017 Mar;12(1):31-50. doi: 10.1007/s11481-016-9692-7. Epub 2016 Jul 2. J Neuroimmune Pharmacol. 2017. PMID: 27372507 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources